Ares Capital Corp
NASDAQ:ARCC
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
19.8
22.18
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Ares Capital Corp
Ares Capital Corp
Net Issuance of Common Stock
Ares Capital Corp
Net Issuance of Common Stock Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Ares Capital Corp
NASDAQ:ARCC
|
Net Issuance of Common Stock
$1.1B
|
CAGR 3-Years
16%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
4%
|
|
|
Ameriprise Financial Inc
NYSE:AMP
|
Net Issuance of Common Stock
-$2.1B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-1%
|
|
|
KKR & Co Inc
NYSE:KKR
|
Net Issuance of Common Stock
-$102.9m
|
CAGR 3-Years
48%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
BlackRock Inc
NYSE:BLK
|
Net Issuance of Common Stock
-$1.6B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-2%
|
|
|
Bank of New York Mellon Corp
NYSE:BK
|
Net Issuance of Common Stock
-$3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-10%
|
|
|
Blackstone Inc
NYSE:BX
|
Net Issuance of Common Stock
-$603.7m
|
CAGR 3-Years
5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-33%
|
|
Ares Capital Corp
Glance View
In the realm of business development companies, Ares Capital Corp (ARCC) has carved a prominent niche by focusing on being a crucial capital provider to middle-market companies across a wide array of industries. Established with the aim of facilitating growth and expansion for businesses that might otherwise struggle to access traditional financial markets, ARCC functions by extending various forms of debt and equity capital solutions. Its operations primarily revolve around providing senior secured loans, unsecured loans, and to a lesser extent, equity investments. This strategic approach allows ARCC to earn interest income on its loan portfolio, positioning itself as a pivotal alternative lender in the financial ecosystem. Ares Capital's success hinges on its deeply ingrained ability to balance risk and reward, carefully curating its investment portfolio to ensure steady, reliable returns while mitigating potential losses. By maintaining a diversified portfolio, both in terms of sector exposure and geographical distribution, ARCC cushions itself against market volatility and economic downturns. Fundamentally, the firm generates revenue through the interest income and capital gains from its investments. With a keen eye on underwriting standards and thorough due diligence, Ares Capital ensures that it not only provides much-needed financial support to its portfolio companies but also secures its own financial health, delivering value to its stakeholders in the process.
See Also
What is Ares Capital Corp's Net Issuance of Common Stock?
Net Issuance of Common Stock
1.1B
USD
Based on the financial report for Sep 30, 2024, Ares Capital Corp's Net Issuance of Common Stock amounts to 1.1B USD.
What is Ares Capital Corp's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 10Y
4%
Over the last year, the Net Issuance of Common Stock growth was -4%. The average annual Net Issuance of Common Stock growth rates for Ares Capital Corp have been 16% over the past three years , and 4% over the past ten years .
You don't have any saved screeners yet
